← Open Payments lookup

KAROLINA FAYSMAN: Open Payments

NPI 1336320407 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$258,328 in 342 payments from 19 companies in 2025. Trend: 2023 $216,798 · 2024 $196,364 · 2025 $258,328

Speaker / faculty: $202,983Travel & lodging: $42,222Food & beverage: $9,543Consulting: $3,580
CompanyPaymentsAmount
Janssen Biotech, Inc.80$70,455
SOBI, INC72$62,832
Incyte Corporation72$56,478
Syndax Pharmaceuticals, Inc.31$25,087
GlaxoSmithKline, LLC.21$11,422
PFIZER INC.15$9,514
Genmab U.S., Inc.10$7,364
ABBVIE INC.8$7,122
BeOne Medicines USA, Inc.8$4,526
BeiGene USA, Inc.2$1,620

Products named: RYBREVANT, Vonjo, Niktimvo, Monjuvi, REVUFORJ, EPKINLY, ELREXFIO, OJJAARA.

Industry payments across CA — which companies pay providers there.